X-PHARM INVESTMENTS LIMITED

X-PHARM INVESTMENTS LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source
  • Overview

    Company NameX-PHARM INVESTMENTS LIMITED
    Company StatusActive
    Legal FormPrivate limited company
    Company Number 13613253
    JurisdictionEngland/Wales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of X-PHARM INVESTMENTS LIMITED?

    • Other letting and operating of own or leased real estate (68209) / Real estate activities

    Where is X-PHARM INVESTMENTS LIMITED located?

    Registered Office Address
    4 Progress Business Centre
    SL1 6DQ Slough
    Berkshire
    England
    Undeliverable Registered Office AddressNo

    What are the latest accounts for X-PHARM INVESTMENTS LIMITED?

    OverdueNo
    Next Accounts
    Next Accounts Period End OnMar 31, 2025
    Next Accounts Due OnMar 31, 2026
    Last Accounts
    Last Accounts Made Up ToMar 31, 2024

    What is the status of the latest confirmation statement for X-PHARM INVESTMENTS LIMITED?

    Last Confirmation Statement Made Up ToSep 10, 2026
    Next Confirmation Statement DueSep 24, 2026
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToSep 10, 2025
    OverdueNo

    What are the latest filings for X-PHARM INVESTMENTS LIMITED?

    Filings
    DateDescriptionDocumentType

    Confirmation statement made on Sep 10, 2025 with no updates

    3 pagesCS01

    Registration of charge 136132530005, created on Apr 08, 2025

    39 pagesMR01

    Registration of charge 136132530006, created on Apr 08, 2025

    39 pagesMR01

    Registration of charge 136132530007, created on Apr 08, 2025

    39 pagesMR01

    Registration of charge 136132530002, created on Feb 19, 2025

    40 pagesMR01

    Registration of charge 136132530003, created on Feb 19, 2025

    37 pagesMR01

    Registration of charge 136132530004, created on Feb 19, 2025

    33 pagesMR01

    Total exemption full accounts made up to Mar 31, 2024

    8 pagesAA

    Second filing of Confirmation Statement dated Sep 10, 2022

    3 pagesRP04CS01

    Confirmation statement made on Sep 10, 2024 with no updates

    3 pagesCS01

    Statement of capital following an allotment of shares on Nov 02, 2021

    • Capital: GBP 300
    3 pagesSH01

    Accounts for a dormant company made up to Mar 31, 2023

    2 pagesAA

    Registration of charge 136132530001, created on Dec 15, 2023

    4 pagesMR01

    Confirmation statement made on Sep 10, 2023 with no updates

    3 pagesCS01

    Accounts for a dormant company made up to Mar 31, 2022

    2 pagesAA

    Current accounting period shortened from Sep 30, 2022 to Mar 31, 2022

    1 pagesAA01

    Confirmation statement made on Sep 10, 2022 with no updates

    4 pagesCS01
    Annotations
    DateAnnotation
    Oct 22, 2024Clarification A second filed CS01 (statement of capital & shareholder information change) was registered on 22/10/2024.

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolutions

    Share exchange agreement 02/11/2021
    RES13
    capital

    Resolution of allotment of securities

    RES10

    Incorporation

    35 pagesNEWINC
    Associated Filings
    CategoryDateDescriptionType
    capitalSep 10, 2021

    Statement of capital on Sep 10, 2021

    • Capital: GBP 3
    SH01

    Who are the officers of X-PHARM INVESTMENTS LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    AHMED, Farook
    Progress Business Centre
    SL1 6DQ Slough
    4
    Berkshire
    England
    Director
    Progress Business Centre
    SL1 6DQ Slough
    4
    Berkshire
    England
    United KingdomBritish287118870001
    DHALIWAL, Bhupinder, Mr
    Progress Business Centre
    SL1 6DQ Slough
    4
    Berkshire
    England
    Director
    Progress Business Centre
    SL1 6DQ Slough
    4
    Berkshire
    England
    United KingdomBritish287118850001
    SEHMI, Gurdev
    Progress Business Centre
    SL1 6DQ Slough
    4
    Berkshire
    England
    Director
    Progress Business Centre
    SL1 6DQ Slough
    4
    Berkshire
    England
    United KingdomBritish287118860001

    Who are the persons with significant control of X-PHARM INVESTMENTS LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Mr Bhupinder Dhaliwal
    Progress Business Centre
    SL1 6DQ Slough
    4
    Berkshire
    England
    Sep 10, 2021
    Progress Business Centre
    SL1 6DQ Slough
    4
    Berkshire
    England
    No
    Nationality: British
    Country of Residence: United Kingdom
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.
    Mr Gurdev Sehmi
    Progress Business Centre
    SL1 6DQ Slough
    4
    Berkshire
    England
    Sep 10, 2021
    Progress Business Centre
    SL1 6DQ Slough
    4
    Berkshire
    England
    No
    Nationality: British
    Country of Residence: United Kingdom
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.
    Mr Farook Ahmed
    Progress Business Centre
    SL1 6DQ Slough
    4
    Berkshire
    England
    Sep 10, 2021
    Progress Business Centre
    SL1 6DQ Slough
    4
    Berkshire
    England
    No
    Nationality: British
    Country of Residence: United Kingdom
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0